Dr Kennedy Kipkoech is a Senior Research Associate in Infectious Diseases mathematical modelling at the University of Bristol, United Kingdom. His research specialty and interest are in the application of epidemiological, statistical, and mathematical modelling approaches to understand transmission dynamics and control of infectious diseases, particularly HIV and viral hepatitis.

Mariam is a PhD candidate in Epidemiology at McGill University, where she also completed her Master of Science in Public Health. She is interested in identifying gaps in care people who inject drugs and are living with HCV face to inform holistic elimination strategies that improve overall health outcomes.

Cathy Long is a community-based researcher whose work seeks to understand and respond to gaps in social and health services, with an emphasis on equity for people who use substances and people experiencing homelessness. Long has a PhD in social and behavioural health sciences from the University of Toronto.

David Goodman-Meza is a Senior Research Associate in the Kirby Institute, UNSW Sydney since 2024. He is a clinician-scientist with expertise in Infectious Diseases and Addiction Medicine.

Mohammad Shoriful Alam (MPH), native of Bangladesh working around twenty years as an activist in the area of HIV Intervention program among PWID and PLHIV.

Theresa Caruana is a Post-Doctoral Fellow at the Centre for Social Research in Health, UNSW Sydney. Her recent PhD investigated the experiences of people receiving opioid pharmacotherapies from community pharmacies, and her current research focuses on stigma in health settings. She has a history of working with populations experiencing disadvantage in a variety of direct practice, education, and communication roles.

Michelle Pittman is a mental health and addictions Nurse Practitioner in Fredericton, New Brunswick Canada. She began her nursing career in 2016 in community health and later became the nurse and clinic manager at River Stone Recovery Centre—the first injectable opioid agonist therapy (iOAT) program in Atlantic Canada. Michelle completed her Master of Nursing at Athabasca University in 2023 and is now a Nurse Practitioner at RECAP Health Services, continuing to serve individuals with substance use disorder and complex mental health needs. Michelle also operates a nurse-led Hepatitis C treatment program that has reached WHO eradication targets within the iOAT population. She is active in provincial, national and international advocacy and education, serving on the steering committee of Action Hepatitis Canada, the nurses committee of INHSU, co-lead for CanHepC’s New Brunswick provincial HCV road map development, Board of Directors for Canadian Association of Hepatology Nurses and CATIE Information Exchange. Outside of her professional roles, Michelle is a proud wife and mother to an adventurous 4-year-old.

Jacqui is a nurse working at the Burnet Institute in the Eliminate hepatitis C Australia partnership. Jane works at Harm Reduction Victoria and is an advocate of peer work and lived experience and is passionate about the health and human rights of people who use drugs.

Jane has been working with people who use drugs in various front line roles for more than twenty years. She currently coordinates the health promotion team and the DOPE project at Harm Reduction Victoria. She has a seat on the board of AIVL, the peak body for drug user organisations in Australia and INPUD, the International Network of People Who Use Drugs. She is passionate about the health and human rights of people who use drugs and is a strong advocate against stigma and discrimination toward her community. She is a huge dog lover who also happens to be dependent on cheesy reality television and heroin.